Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 2,784 Shares

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 2,784 shares of the business’s stock in a transaction on Monday, March 24th. The shares were sold at an average price of $50.00, for a total transaction of $139,200.00. Following the completion of the sale, the director now directly owns 295,810 shares of the company’s stock, valued at approximately $14,790,500. This trade represents a 0.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Pro-Dex Price Performance

Shares of NASDAQ PDEX opened at $49.98 on Friday. The stock has a market cap of $162.98 million, a P/E ratio of 24.87 and a beta of 0.68. Pro-Dex, Inc. has a twelve month low of $16.84 and a twelve month high of $59.60. The stock has a 50 day moving average of $40.13 and a two-hundred day moving average of $39.75. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.33.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. On average, research analysts forecast that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Institutional Investors Weigh In On Pro-Dex

Several hedge funds have recently made changes to their positions in the business. EAM Investors LLC acquired a new position in Pro-Dex in the 4th quarter valued at about $1,047,000. O Shaughnessy Asset Management LLC acquired a new position in shares of Pro-Dex in the fourth quarter valued at approximately $995,000. 683 Capital Management LLC purchased a new stake in shares of Pro-Dex during the fourth quarter worth approximately $739,000. Ritholtz Wealth Management purchased a new stake in shares of Pro-Dex during the fourth quarter worth approximately $572,000. Finally, American Century Companies Inc. acquired a new stake in shares of Pro-Dex during the fourth quarter worth $558,000. Institutional investors and hedge funds own 15.28% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com cut Pro-Dex from a “buy” rating to a “hold” rating in a research report on Wednesday, March 12th.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.